DE60135919D1 - Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate - Google Patents
Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivateInfo
- Publication number
- DE60135919D1 DE60135919D1 DE60135919T DE60135919T DE60135919D1 DE 60135919 D1 DE60135919 D1 DE 60135919D1 DE 60135919 T DE60135919 T DE 60135919T DE 60135919 T DE60135919 T DE 60135919T DE 60135919 D1 DE60135919 D1 DE 60135919D1
- Authority
- DE
- Germany
- Prior art keywords
- chinazole
- heterocyclylmethyl
- chinoline
- inhibiting
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00203368 | 2000-09-25 | ||
EP01202190 | 2001-06-07 | ||
PCT/EP2001/010894 WO2002024686A2 (en) | 2000-09-25 | 2001-09-18 | Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60135919D1 true DE60135919D1 (de) | 2008-11-06 |
Family
ID=26072730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60135919T Expired - Lifetime DE60135919D1 (de) | 2000-09-25 | 2001-09-18 | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate |
Country Status (8)
Country | Link |
---|---|
US (1) | US7196094B2 (de) |
EP (1) | EP1322650B1 (de) |
JP (1) | JP4974438B2 (de) |
AT (1) | ATE409189T1 (de) |
AU (1) | AU2002220559A1 (de) |
DE (1) | DE60135919D1 (de) |
ES (1) | ES2313991T3 (de) |
WO (1) | WO2002024686A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2361B1 (en) | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl |
EP1408971A4 (de) | 2001-06-21 | 2006-01-25 | Ariad Pharma Inc | Neue chinoline und ihre verwendungszwecke |
AU2003223970B2 (en) * | 2002-03-22 | 2008-03-06 | Janssen Pharmaceutica N.V. | Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
AU2003229688B2 (en) | 2002-04-15 | 2009-07-30 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
WO2004076446A1 (ja) * | 2003-02-27 | 2004-09-10 | Chugai Seiyaku Kabushiki Kaisha | ベンゾチオフェン誘導体 |
JP4722851B2 (ja) * | 2003-09-23 | 2011-07-13 | メルク・シャープ・エンド・ドーム・コーポレイション | キノリンカリウムチャネル阻害剤 |
US20050154451A1 (en) * | 2003-12-18 | 2005-07-14 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050288298A1 (en) * | 2004-03-18 | 2005-12-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
JP2007538004A (ja) * | 2004-03-18 | 2007-12-27 | ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド | シヌクレイノパチーを治療する方法 |
US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
US20050277629A1 (en) * | 2004-03-18 | 2005-12-15 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies (Lansbury) |
US20050272068A1 (en) * | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | UCH-L1 expression and cancer therapy |
WO2006017369A2 (en) * | 2004-07-13 | 2006-02-16 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of a farnesyl transferase inhibitor in the treatment of viral infections |
US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
EP1968591A4 (de) | 2005-12-23 | 2010-02-17 | Link Medicine Corp | Behandlung von synucleinopathien |
MX2008010953A (es) * | 2006-02-28 | 2008-09-08 | Amgen Inc | Derivados de cinolina y quinoxalina como inhibidores de la fosfodiesterasa 10. |
US8232402B2 (en) * | 2008-03-12 | 2012-07-31 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
EP2365809B8 (de) | 2008-11-12 | 2018-10-10 | Ariad Pharmaceuticals, Inc. | Pyrazinopyrazine und derivate als kinasehemmer |
MX2011005096A (es) * | 2008-11-13 | 2011-11-18 | Link Medicine Corp | Derivados de azaquinolinona y usos de los mismos. |
US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
CA2888485C (en) | 2012-10-16 | 2021-01-26 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of ror.gamma.t |
KR20150070348A (ko) | 2012-10-16 | 2015-06-24 | 얀센 파마슈티카 엔.브이. | RoRγt의 헤테로아릴 결합 퀴놀리닐 조절제 |
PT2909192T (pt) | 2012-10-16 | 2017-08-04 | Janssen Pharmaceutica Nv | Moduladores de ror-gama-t quinolinilo ligados por metileno |
US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
ES2742843T3 (es) | 2013-10-15 | 2020-02-17 | Janssen Pharmaceutica Nv | Moduladores de quinolinilo de ROR(gamma)t |
WO2015057629A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | ALKYL LINKED QUINOLINYL MODULATORS OF RORyt |
US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2002864C (en) | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
NZ320244A (en) | 1995-12-08 | 1999-06-29 | Janssen Pharmaceutica Nv | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
TW591030B (en) | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
AU738628B2 (en) * | 1997-04-25 | 2001-09-20 | Janssen Pharmaceutica N.V. | Farnesyltransferase inhibiting quinazolinones |
TR199902923T2 (xx) | 1997-06-02 | 2000-11-21 | Janssen Pharmaceutica N.V. | Yumu�ak kas h�cresi �o�almas� inhibit�rleri olarak (imidazol-5-il)metil-2-kuinolinon t�revleri. |
SK285231B6 (sk) | 1998-07-06 | 2006-09-07 | Janssen Pharmaceutica N. V. | Použitie 6-[(imidazol-5-yl)metyl]chinolínovej zlúčeniny na prípravu farmaceutickej kompozície na liečbu artropatie |
PL193464B1 (pl) | 1998-07-06 | 2007-02-28 | Janssen Pharmaceutica Nv | Zastosowanie inhibitora białkowej transferazy farnezylowej |
AU4925199A (en) * | 1998-08-27 | 2000-03-21 | Pfizer Products Inc. | Quinolin-2-one derivatives useful as anticancer agents |
BRPI9913138B8 (pt) * | 1998-08-27 | 2016-05-17 | Osi Pharm Inc | derivado de quinolin-2-ona substituído com alquinila e composição farmacêutica contendo o mesmo |
KR100712226B1 (ko) | 1998-12-23 | 2007-04-27 | 얀센 파마슈티카 엔.브이. | 1,2-어닐링된 퀴놀린 유도체 |
ES2243228T3 (es) * | 1999-02-11 | 2005-12-01 | Pfizer Products Inc. | Derivados quinolin-2-ona sustituidos con heteroarilo utiles como agentes anticancerigenos. |
-
2001
- 2001-09-18 AU AU2002220559A patent/AU2002220559A1/en not_active Abandoned
- 2001-09-18 DE DE60135919T patent/DE60135919D1/de not_active Expired - Lifetime
- 2001-09-18 JP JP2002529096A patent/JP4974438B2/ja not_active Expired - Fee Related
- 2001-09-18 WO PCT/EP2001/010894 patent/WO2002024686A2/en active IP Right Grant
- 2001-09-18 US US10/381,361 patent/US7196094B2/en not_active Expired - Lifetime
- 2001-09-18 AT AT01985254T patent/ATE409189T1/de not_active IP Right Cessation
- 2001-09-18 ES ES01985254T patent/ES2313991T3/es not_active Expired - Lifetime
- 2001-09-18 EP EP01985254A patent/EP1322650B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1322650A2 (de) | 2003-07-02 |
WO2002024686A3 (en) | 2002-06-13 |
JP4974438B2 (ja) | 2012-07-11 |
EP1322650B1 (de) | 2008-09-24 |
US20030207887A1 (en) | 2003-11-06 |
AU2002220559A1 (en) | 2002-04-02 |
JP2004509887A (ja) | 2004-04-02 |
ES2313991T3 (es) | 2009-03-16 |
WO2002024686A2 (en) | 2002-03-28 |
ATE409189T1 (de) | 2008-10-15 |
US7196094B2 (en) | 2007-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60135919D1 (de) | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate | |
SE0000540D0 (sv) | New compounds | |
CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
CY1105386T1 (el) | Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου | |
DK1242382T3 (da) | Tricycliske proteinkinaseinhibitorer | |
CY1107634T1 (el) | Φαρμακευτικη συνθεση | |
DOP2001000151A (es) | Derivados de imidazopirimidina y derivados de triazolopimidina. | |
JO2654B1 (en) | Multiple aryl caroxa amides are useful as lipid - lowering agents | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
CY1111317T1 (el) | Παραγωγα 4-φαινυλοπυριδινης και χρηση αυτων ως ανταγωνιστων υποδοχεων της νκ-1 | |
BR0213981A (pt) | Fotoiniciadores difuncionais | |
CY1109886T1 (el) | Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες | |
EA199900373A2 (ru) | Фармацевтические композиции | |
EA200300566A1 (ru) | Применение cci-779 в качестве противоопухолевого средства | |
GB0127903D0 (en) | Improvements relating to organic compounds | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
PT1181294E (pt) | Novos derivados e analogos da galantamina | |
SE0103710D0 (sv) | Compounds | |
SE9801494D0 (sv) | Novel use | |
SV2003000981A (es) | Fenil-heterociclil-eteres ref. pcs10973 | |
BRPI0416678A (pt) | pirazolpirimidinas | |
DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
BR0206922A (pt) | Compostos orgânicos | |
ATE321760T1 (de) | N-aryl-2-oxazolidinone und deren derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |